- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
2.—(1) Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order) shall be amended in accordance with the following provisions of this article.
(2) In Table A (internal or external use)—
(a)delete the entry “Noscapine” in column 1 and the entry “15mg (MD) 60mg (MDD)” in relation to it in column 4; and
(b)delete the entry “Noscapine Hydrochloride” in column 1 and the entry “Equivalent to 15mg of Noscapine (MD) Equivalent to 60mg of Noscapine (MDD)” in relation to it in column 4.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: